Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “t-cell”

88 pharma patents match "t-cell" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 88
Index total 30,257
Page 1 / 4

Quick answer

This filtered view shows 88 pharmaceutical patents matching "t-cell" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

88 results for “t-cell” · 30,257 patents in full index Clear search

  1. US 12421316

    Bispecific immunotoxins targeting human CD25+CCR4+ tumors and regulatory T-cells

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 12421287

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  3. US 12304942

    Cell comprising a chimeric antigen receptor or a transgenic T-cell receptor and comprising a chimeric TNF receptor

    AUTOLUS LIMITED · Granted May 20, 2025 · Expires May 15, 2045

    granted
  4. US 12304968

    T-cells expressing anti-LIV1 chimeric antigen receptor

    CRISPR THERAPEUTICS AG · Granted May 20, 2025 · Expires May 15, 2045

    granted
  5. US 12297452

    Methods or generating T-cells from stem cells and immunotherapeutic methods using the T-cells

    The Regents of the University of California · Granted May 13, 2025 · Expires May 8, 2045

    granted
  6. US 12257311

    Multimeric T-cell modulatory polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  7. US 12215162

    BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  8. US 12195724

    Methods of producing T cell populations enriched for stable regulatory T-cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 14, 2025 · Expires Jan 9, 2045

    granted
  9. US 12187780

    Car t-cells comprising inactivated CBL and CBL-B genes

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  10. US 12180258

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  11. US 12152061

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  12. US 12145973

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  13. US 12139522

    T-cells comprising two different chimeric antigen receptors and uses thereof

    THE MEDICAL RESEARCH INFRASTRUCTURE AND HEAL SERVICED FUND OF THE TEL AVIV MEDECAL CENTER · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted
  14. US 12104172

    Processes for generating TIL products enriched for tumor antigen-specific t-cells

    Iovance Biotherapeutics, Inc. · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  15. US 12053513

    Cancer-specific T-cell receptors

    University College Cardiff Consultants Limited · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  16. US 12049487

    Universal chimeric antigen receptor T-cell preparation technique

    GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD. · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  17. US 12029782

    MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof

    Cue Biopharma, Inc. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  18. US 12006348

    T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof

    Cue Biopharma, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  19. US 11987610

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  20. US 11944644

    T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  21. US 11905320

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  22. US 11897874

    Compounds and methods for modulating Interleukin-2-inducible T-cell kinase

    Corvus Pharmaceuticals, Inc. · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  23. US 11883431

    T-cells modified to overexpress PHF19

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  24. US 11885806

    Method for depleting malignant T-cells

    AUTOLUS LIMITED · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted